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ABSTRACT 18 
It is important during powder granulation to obtain particles of a homogeneous size especially 19 
in critical situations such as pharmaceutical manufacture. To date, homogeneity of particle size 20 
distribution has been defined by the use of the d50 combined with the span of the particle size 21 
distribution, which has been found ineffective for polymodal particle size distributions. This 22 
work focuses on demonstrating the limitations of the span parameter to quantify homogeneity 23 
and proposes a novel improved metric based on the transformation of a typical particle size 24 
distribution curve into a homogeneity factor which can vary from 0 to 100%. The potential of 25 
this method as a characterisation tool has been demonstrated through its application to the 26 
production of granules using two different materials. The workspace of an 11 mm twin screw 27 
granulator was defined for two common excipients (Į-lactose monohydrate and 28 
microcrystalline cellulose). Homogeneity of the obtained granules varied dramatically from 0 29 
to 95 % in the same workspace, allowing identification of critical process parameters (e.g. feed 30 
rate, liquid/solid ratio, torque velocities). In addition it defined the operational conditions 31 
required to produce the most homogeneous product within the range 5 ȝP± 2.2 mm from both 32 
materials.    33 
Keywords: Twin screw granulation; particle size distribution; homogeneity factor; quality by 34 
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Abbreviations: 41 
A0 Area corresponding to the equivalent minimum homogeneity of PSD 42 
A100 Area corresponding to the equivalent maximum homogeneity of PSD 43 
APSD Area corresponding to the PSD 44 
DoE    Design of experiments 45 
dx Intercept x of the cumulative volume  46 
d Diameter 47 
FH Homogeneity factor 48 
k1 Sorting factor parameter 49 
k2 Sorting factor parameter 50 
L/S Liquid/Solid ratio 51 
ȝ Mean value 52 
ninterv Number of intervals 53 
p Percentage of the value of the population 54 
PSD Particle Size Distribution 55 
QbD Quality by Design  56 
qx Density distribution 57 
Qx Cumulative distribution 58 
s Sorting factor 59 
VMD   Volume mean diameter 60 
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TSG Twin-Screw Granulator  61 
w(d) Weight distribution 62 
wPSD Weight distribution corresponding to the particle size distribution 63 
w0 Weight distribution corresponding to the equivalent minimum homogeneity of PSD 64 
w100 Weight distribution corresponding to the equivalent maximum homogeneity of PSD 65 
xm Particle size 66 
xm0 Particle size of the first value 67 
xmmax Particle size of the maximum peak 68 
69 
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1. INTRODUCTION  70 
Wet granulation is a common industrial unit operation in the pharmaceutical industry for 71 
particle size enlargement.   Although this operation has been traditionally performed in batch, 72 
it could be effectively achieved in a continuous mode using a Twin-Screw Granulator (TSG).   73 
The key advantages of this technology over batch granulation are shorter residence times, 74 
greater flexibility in granule properties and the ability to vary the required throughput. The 75 
understanding of wet granulation has achieved notable advances in the past twenty-five years, 76 
since the macroscopic research of granulation was replaced by a microscopic study of the 77 
variables ((Ennis and Litster, 1997; Ennis, 1991; Parikh, 2005)).    78 
In contrast to batch equipment traditionally used in wet granulation, TSG has been applied by 79 
the pharmaceutical industry as a useful continuous operation granulation technique (Keleb et 80 
al., 2002; Van Melkebeke et al., 2008), which due to the flexibility offered by the equipment 81 
is easier to design and scale up.   Multiple working environments are enabled by the possibility 82 
of changing different sections of the screw assembly, feed port locations, different segment 83 
geometr\¶V or the option of working with a wide range of conditions such as feed rate or 84 
liquid/solid ratio (Dhenge et al., 2011; Djuric and Kleinebudde, 2008; Vercruysse et al., 2012).   85 
Vercruysse (Vercruysse et al., 2013), for example confirmed the successful production of 86 
granules by TSG processes within the specifications defined for the equivalent batch fluid bed 87 
granulation process.  Furthermore, this system was able to manufacture simplified formulations 88 
containing high drug loads of up to 90% (Meier et al., 2015).   On the contrary, other cases 89 
where there is a lack of specific tools to study the operational parameters were driven to 90 
situations where the implementation of TSG was not justified compared to batch systems (Lee 91 
et al., 2013).    92 
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One of the main explanations is that the variation in the conditions produces many different 93 
Particle Size Distributions (PSD) for which the curves differ from the desired unimodal shape 94 
(Yu et al., 2014) achieved during standard batch granulation processes. The appearance of 95 
polymodal distributions is especially prevalent during research into the effects that the 96 
parameters have on granule properties. Particle size distributions vary from unimodal to 97 
polymodal depending on the analysed value or position of the variable. That is especially 98 
remarkable, in the different studies about the influence of the main parameters such as 99 
liquid/solid ratio (L/S) or screw elements (Dhenge et al., 2012; El Hagrasy et al., 2013; Sayin 100 
et al., 2015).    101 
The evaluation of the granulation process requires knowledge of the variance of the granules¶ 102 
properties as function of the process parameters, and, the establishment of the variation using 103 
general terms such as volume, strength, and friability.   The study of these terms gives important 104 
information allowing process control, as well as establishment of the acceptable limits of the 105 
working conditions. However, although terms such as friability or flowability can be expressed 106 
as a single value, particle size distribution is frequently expressed as a curve, which does not 107 
allow its direct examination as a quality attribute or a process control variable. A quality 108 
attribute should be within an appropriate limit, range, or distribution to ensure the desired 109 
product quality (ICH Q8 (R2), 2009).  110 
The separation of a particulate sample into discrete size classes has been traditionally 111 
performed representing the type of quantity in the abscissa and the measure of the quantity in 112 
the ordinate. The measurement of the quantity is made through the relative amount of particles 113 
measured within a specific size interval and it is called density distribution (qx). This term is 114 
the first derivative of the cumulative distribution (Qx) against particle size (Leschonski, 1984).   115 
The subscript x represents the type of quantity where the possible types are number, length, 116 
area, volume or mass. In pharmaceutical sciences, the type of quantity chosen is frequently the 117 
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volume, due to the importance of the relationship between drug delivery and volume (Müllertz 118 
et al., 2016). 119 
Frequently, the volume particle size distributions are characterised by d10,d50 and d90 which are 120 
calculated through the intercepts for 10, 50 and 90 % of the cumulative volume (ISO, 2014).   121 
These terms can be gathered if they are transformed to the span ((d90 ±d10)/d50) (Chitu et al., 122 
2011; El Hagrasy et al., 2013), with particle size distributions considered more homogeneous 123 
the closer this value is to zero. This analysis is only acceptable when the particle size 124 
distribution is lognormal, but will introduce a considerable error when the distributions show 125 
more than one peak and the peaks are located around the mean diameter. For instance, Figure 126 
1 shows two particle size distributions which have two different shapes but very close span 127 
values.  The first shape (Figure 1a) could be considered to be a common lognormal distribution 128 
where all the values are around the main peak.   However, the second shape (Figure 1b) displays 129 
three peaks of different population densities which indicates that three main types of granules 130 
exist in the sample. Nevertheless, the difference between spans of those distributions is less 131 
than 2%, and therefore both distributions would be comparable in terms of homogeneity even 132 
if they are clearly different in the number of peaks.  133 
In sedimentology an alternative method has been applied to transform the normal distribution 134 
for unimodal and bimodal distributions known as the hyperbolic tangent technique (tanh 135 
method), which has been used traditionally for dealing with travelling waves and to study 136 
evolution equations (Malfliet, 2004).   It was successfully applied by Passe (Passe, 1997) in 137 
order to transform a grain distribution into a mathematical expression.   Due to the fact that the 138 
graphical result of the integral of a normal distribution presents an analogous shape to the 139 
hyperbolic tangent function; the cumulative expression can be mathematically described by 140 
Eq. 1. 141 
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ݓሺ݀ሻ ൌ ௣ଶ െ ቀ௣ଶቁ כ ሺሺߤሻ െ ሺ݀ሻ כ ݏሻ                                                     Eq. 1 142 
:KHUHZLVWKHZHLJKWȝLVWKHPHDQYDOXHRIWKHparticle size, d is the variable particle size, p 143 
is the value of the population of the different peaks in percentage which is equal to 100% for 144 
unimodal distributions and s is a sorting factor which is given as 1/(log d75 ± log d25 ) (Passe, 145 
1997). 146 
This technique for transforming curves into mathematical expressions can be used as an 147 
effective way to smooth distribution curves due to the variation of the slope depending on the 148 
number of peaks. For example, three different particle size distributions have been transformed 149 
through this method in Figure 2 representing the weight against the logarithm of the particle 150 
size. The first PSD (Figure 2a) can be considered as a mono-modal distribution and its 151 
equivalent weight distribution is a straight line which slopes up at the greatest rate.   The second 152 
PSD (Figure 2b) corresponds to a bimodal distribution and its weight distribution shows an 153 
important decrease of the slope of the curve compared to Figure 2a. The third PSD (Figure 2c) 154 
represents a polymodal distribution with three clear peaks in which the slope of the 155 
corresponding weight distribution curve has decreased even more dramatically with respect to 156 
Figure 2a. Therefore, from Figure 2 it can be concluded that the decreasing slope of the curves 157 
represents the decrease in homogeneity of distribution as well as the increase in the number of 158 
peaks of the distribution.    159 
The direct relationship between the slope of the weight distribution curve and the shape of the 160 
particle size distribution shows an enormous potential as a characterisation tool.  The area under 161 
the resultant curve can be calculated through integration and it will be proportional to the slope 162 
of the curve. The homogeneity can be measured through this method and transformed into a 163 
percentage, unimodal PSDs will be associated with larger areas and greater homogeneity 164 
percentages.    165 
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Transforming PSDs into a homogeneity factor (FH) allows the analysis of the influence of 166 
operational parameters on the system.   In addition, workspaces can be created and the system 167 
can be easily optimised after obtaining the regions where the production of granules is 168 
homogeneous.    169 
Further potential advantages of homogeneity values calculated from particle size distributions 170 
are related to its potential to be used as a characterisation tool for Quality by Design (QbD) 171 
which is recommended for adoption by the pharmaceutical industry (Seem et al., 2015).   This 172 
approach ought to be accomplished with a systematic scientific risk-based methodology, 173 
therefore a tool for characterising granule homogeneity would help to provide a greater 174 
understanding of the underlying process mechanisms.   In addition, it will improve the control 175 
during granule manufacture as well as being a useful complement to other granule properties 176 
such as flowability or strength in the optimisation of tabletting and associated processes. 177 
Besides, the possibility of defining a desired diameter operating point and controlling the 178 
homogeneity around that point allows identification of when the process is within product 179 
specifications. This advantage could be used in the comparison of different batches and 180 
technologies both research and industrial scale.    181 
Due to the possible advantages of quantifying a 36'¶Vhomogeneity with a single numerical 182 
parameter, the aims of this study were to propose a methodology capable of achieving this.   183 
The method developed can transform any PSD into a weight distribution through the hyperbolic 184 
tangent method and calculate a homogeneity percentage. Furthermore, this method was 185 
mathematically validated through the study of the response to simulated scenarios of particle 186 
size distributions and empirically demonstrated through the application to two different 187 
materials Į-Lactose monohydrate and microcrystalline cellulose) and its potential as 188 
characterisation tool was assessed by determining the most critical process parameters for both 189 
systems.     190 
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2.  MATERIALS AND METHODS 191 
2.1. Materials 192 
Į-Lactose monohydrate (PubChem CID: 24896349 ) with 99% total lactose basis (GC) (Sigma-193 
Aldrich Company Ltd., Dorset, England) and microcrystalline cellulose (PubChem CID: 194 
:16211032) with average particle size 50 µm (Fisher Scientific UK Ltd, Loughborough, 195 
Leicestershire, United Kingdom) were used as excipients to validate the method.  Distilled 196 
water (0'0LOOLSRUH3XUH:DWHU5HVHUYRLUV0LOOLSRUH6$60RVKHLP)UDQFH was added 197 
as granulation liquid.  198 
2.2 Granulation experiments 199 
In order to produce granules, a Thermofisher Pharma 11mm Twin Screw Granulator  (Process 200 
11, 40:1 L/D, Thermo Fisher Scientific, Karlsruhe, Germany) operating within the range of 50-201 
125 rpm in combination with a gravimetric feeder (Brabender Gravimetric feeder DDW-MT, 202 
Brabender Technologie Gmbh & Co. Kg Duisburg, Germany) was employed to feed excipients 203 
at a rate of 0.05-0.35 kg h-1. Distilled water was fed to the system through a syringe pump 204 
(Harvard Syringe Pump, Harvard Apparatus UK, Cambridge, UK) in order to produce 205 
liquid/solid ratios from 0.05 to 0.2 for Į-Lactose monohydrate, and 1 to 1.8 for microcrystalline 206 
cellulose. The upper and lower limits of granule production ratios were chosen since below the 207 
lower limit, the product obtained at these torque velocities was a powder and above the upper 208 
limit the product was a wet mass.  The design of experiments and following analysis was done 209 
through the use of the commercial software Modde 10.1. The chosen model design used to 210 
select the experimental setup and to study the relationship between variables was an Onion D-211 
Optimal model with two layers which was fitted afterwards with PLS-2PLS regression analysis   212 
(MKS Data Analytics Solutions, Malmö, Sweden). Figure 3 displays the design of experiments 213 
for both materials: Į-Lactose monohydrate (Figure 3a) and for microcrystalline cellulose 214 
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(Figure 3b).   The screw configuration used was 27 conveying elements for each sheet, chosen 215 
in order to minimise the impact that the different screw elements could have on the granules 216 
(Seem et al., 2015). 217 
2.3 Offline granule size analysis 218 
The analysis of the granule size distribution was performed using the QICPIC/RODOS L with 219 
vibratory feeder VIBRI/L (Sympatec GmbH System-Partikel-Technik, Clausthal-Zellerfeld, 220 
Germany).   221 
All the particle size distributions obtained were produced at 0.5 bar of primary pressure to 222 
avoid breakage of the granules during the analysis (MacLeod and Muller, 2012). The disperser 223 
conditions were optimised for each set of granules to obtain the optimal optical concentration.   224 
All the particle size distributions were plotted in logarithmic volume against the particle size. 225 
The volumetric mean diameter (VMD) determined by the system was chosen as mean diameter, 226 
and is been calculated based in the arithmetic mean value.    227 
2.4 Quantification of homogeneity method 228 
To quantify homogeneity PSD curves are smoothed through the hyperbolic tangent method in 229 
order to adapt the data to the mathematical expression in Eq. 2 based in the equation used by 230 
Passe. (Passe, 1997).    231 
ݓሺݔ݉ሻ ൌ ෍ ቀ݌௜ ?െ ݌௜ ?כ ሺሺߤ௜ሻ െ ሺݔ݉ሻ כ ݏ௜ቁ௜ୀ௧௢௧௔௟ ௣௘௔௞௦ ଴  233 
                       Eq. 2 232 
Where the subindex i represents the peak number for appearance order, pi is the value of the 234 
population of the peak in percentage, ȝi is the mean value of the particle size for the peak width, 235 
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xm is the size of the particles included in the width of the peak, and si is a sorting factor defined 236 
in Eq 3.  237 
This mathematical expression depends on the total number of peaks and a specific expression 238 
needs to be developed for each peak. The peaks are local maxima of the particle size 239 
distribution. The local maximum is located as the data point which is larger than its two 240 
neighbouring points, in those cases that the top of the peak is flat, the point considered is the 241 
first to appear (The MathWorks Inc, 2013). After locating the peaks, their amplitude was 242 
calculated by means of the integral of the curve formed by the peak.    243 
The sorting factors for each PSD curve are calculated using Eq 3 were d25 and d75 are the 244 
diameter corresponding to the 25% and 75% population weight of each peak. The sorting factor 245 
was adapted from the method presented by Passe (Passe, 1997) through the introduction of the 246 
terms k1 and k2 which were developed in house for the range 5 ȝP± 2.2 mm. The term k1 247 
weights the difference between the peak corresponding to maximum value in the density 248 
distribution and the volumetric mean diameter of the particles (Eq. 4).   Frequently, the limits 249 
of the ranges of particles sizes distribution are proportional to the size of particle and those 250 
could be different depending on the choice of nest of sieves or the measuring range of the 251 
analytical system. To avoid the effect of these possible discrepancies between the different 252 
methods, the distribution will be normalised when one considers that it is composed of ten 253 
identical intervals.   The difference between the maximum peak and the mean diameter will be 254 
measured through the number of intervals between them (Eq. 5).  255 
ݏ௜ ൌ ݇ଵ כ ௣೔୪୭୥ሺௗళఱሻି୪୭୥ሺௗమఱሻ Eq. 3 256 
݇ଵ ൌ  ቀെ ቀ௫௠ౣ౗౮ ೛೐ೌೖିௗ௞మ ቁቁ Eq.4 257 ݇ଶ ൌ  ? ?כ ௫௠೗ೌೞ೟ି௫௠బ௡೔೙೟೐ೝೡೌ೗  Eq. 5 258 
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After the particle size distributions have been smoothed, it is required to achieve the maximum 259 
homogeneity possible, e.g. the distribution obtained when all the granules would have the same 260 
diameter and that coincides with the mean diameter. The maximum homogeneity corresponds 261 
to the best case scenario of a unimodal distribution where the first value which would appear 262 
would be unique and it would produce a single peak. After this equivalent perfect particle size 263 
distribution has been calculated, it is possible to calculate the weight distribution for that case. 264 
The lower limits corresponding to zero homogeneity would be represented by the curves 265 
produced when all the sizes have the same weight inside the distribution. As in the case of the 266 
perfect distribution, the PSD needs to be transformed to worst case scenario, allowing the 267 
weight distribution to be calculated. Figure 4 displays the situation where both maximum and 268 
minimum cases have been transformed into their equivalent distribution. The differences in the 269 
rise of both curves allow to distinguish clearly between them as the curve corresponding to 270 
100% homogeneity has a slope 15 times greater than the curve corresponding to 0%.    271 
Once the upper and lower limits have been determined, it is possible to calculate the 272 
homogeneity for any particle size distribution by calculating the area under the curve 273 
corresponding to the PSD and its equivalent best (100% homogeneity) and worst (0% 274 
homogeneity) cases. Figure 5 displays the three areas in different colours.   The area 275 
corresponding to 100% homogeneity would be comprised between the solid and dotted black 276 
lines with the PSD area shaded in yellow. Since the particle size distribution is given in 277 
intervals, it was chosen to obtain the area under curve through the trapezoidal rule (Treiman, 278 
2014).    279 
The homogeneity factor can then be calculated as percentage using Eq. 6.    280 
ܨܪሺ ?ሻ ൌ  ? ? ?െ  ? ? ?כ ቀ ׬ ௪ುೄವሺ୪୭୥ሺ௫௠ሻሻௗ௫ି׬ ௪బሺ୪୭୥ሺ௫௠ሻሻௗ௫׬ ௪భబబሺ୪୭୥ሺ௫௠ሻሻௗ௫ି׬ ௪ುೄವሺ୪୭୥ሺ௫௠ሻሻௗ௫ቁ                       ї 281 
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ܨܪሺ ?ሻ ൌ  ? ? ?െ ஺ುೄವି஺బ஺భబబି஺బ כ  ? ? ? Eq. 6 282 
A summary of the methodology can be found in a flowchart in Figure 6.   283 
All the data and analysis processing were performed using the commercial software package 284 
Matlab (can be found under the supplemental information) and Statistics Toolbox R2014a (The 285 
MathWorks, Inc., Natick, Massachusetts, United States).    286 
2.5 Contour profiles 287 
The results and the effects of the different variables will be presented as contour plots, which 288 
are able to show multidimensional interactions between the input variables and process 289 
parameters. The contour profiles are a recommended tool to identify the design space of a full 290 
workspace (ICH Q8 (R2), 2009). These profiles are built identifying which combinations of 291 
the selected parameters produce the same result on the chosen variable and identifying them 292 
with the same contour.  293 
In this case, for each material analysed four different profiles were produced. Two for each 294 
quality attribute (homogeneity factor and volumetric mean diameter) at two different ranges of 295 
torque velocity (50-87.5 rpm and 87.5-125 rpm). The chosen process parameters were the mass 296 
feed rate of the solid and the liquid/solid ratio (L/S) which is defined as the relationship between 297 
the mass feed rate of the solid and the liquid. A schematic of the Design of experiments (DoE) 298 
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3. RESULTS and DISCUSSION 305 
3.1 Verification of the methodology 306 
According to Eq.2, the homogeneity factor is sensitive to changes in factors such as the number 307 
of the peaks or the width of the distribution.   The methodology was verified through comparing 308 
the response of different simulated distributions with volumetric mean diameter equal to 1000 309 
ȝP 310 
In the first case (Figure 7a), the effect of modification of the distribution shape was studied 311 
through the increase of the standard deviation of the distributions from 0.1 to 0.25. The increase 312 
of the standard deviation in a unimodal distribution produced a direct change in the width of 313 
the distribution, and as Figure 7a shows that affects directly in the FH.  Additionally, Figure 7e 314 
shows the trend for greater increases in the standard deviation.     315 
In the second case, the effect of introducing a peak (Figure 7b) and three peaks (Figure 7c) can 316 
be studied in two different widths. The effect of introducing a new peak produced a fall in the 317 
homogeneity as the initial homogeneity is considerably lower than that corresponding to a 318 
single peak for both widths.  Figure 7f shows the effect of the increase of number of peaks from 319 
a unimodal distribution with a standard deviation of 0.25 to five peaks in the same width. As it 320 
can see, the addition of peaks produce dramatic falls in the homogeneity.    321 
In the last case (Figure d and g), the distance between peaks was studied. The FH is sensitive 322 
to the introduction and distance between peaks as the two peaks are far apart showed a lesser 323 
degree of homogeneity than when they were closer (Figure 7d).    324 
Other factors which will affect the FH are the distance between the volumetric mean diameter 325 
and the main peak.   Those cases in which the diameter is situated around the main peak will 326 
have greater homogeneity than those in which the diameter is more distant.    327 
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To illustrate this the analysis was applied to three different real samples (see Figure 8) where 328 
the homogeneity varied from 0 to 75%.   In the first case (Figure 8a) homogeneity is negligible 329 
(0%), since the sample has three main classes of particles with two of them with similar 330 
intensity in the density curve.   However, the volumetric mean diameter (VMD) is skewed by 331 
a greater percentage of fines which reduces dramatically the homogeneity.   In the second case 332 
(Figure 8b), there are again three classes of particles but even if the width is bigger than in the 333 
other cases, the mean diameter is placed closer to the middle of the three peaks.   Therefore, 334 
the sample is more homogeneous than previous case as the VMD is closer to the biggest peak 335 
(38.3%).   In the third case (Figure 8c), the PSD shape is more similar to a lognormal 336 
distribution suggesting the product is more homogeneous (74.8%). In this example, most of the 337 
particles have the same diameter. This can be observed from the PSD as well as from the 338 
photographs (Figures 8a-c).  339 
 3.2 Application of the methodology 340 
The methodology was applied to granules produced in the TSG with two different excipients 341 
commonly used in pharmaceutical processing, Į-Lactose monohydrate and microcrystalline 342 
cellulose, in a wide range of conditions. The results allow understanding of the influence 343 
different parameters have on the product homogeneity.    344 
The results obtained were presented through contour profiles (Figure 9 and 10). These types of 345 
graphs are really effective for summarising entire workspaces.   On one hand, once the region 346 
of the desired diameter has been located, the operational conditions which produce the most 347 
homogeneous granules for that exact diameter can be easily determined.. On the other hand, 348 
the contour profiles allow examination of the effects that operational parameters have over the 349 
chosen variables.   For instance, on a workspace created by changing the value of two 350 
parameters, it is possible to identify if the response of the variable has been controlled by only 351 
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one or both operational parameters.   That effect would be noticed since the variable would 352 
change linearly and proportionally to the axis of the most relevant parameter.   In those cases, 353 
that the system would vary depending of both parameters, the response of the variable could 354 
adopt different shapes such as slanting or curved lines.  355 
As it can be observed in Figure 9, granules of Į-Lactose monohydrate were produced using 356 
different conditions of liquid/solid (L/S), feed rate and torque velocity.   The results show that 357 
at low torque velocities (Figures 9a and b), the diameter shows higher dependence on the feed 358 
rate than the L/S ratio.   The larger granules are produced when the feed rate is reaching the 359 
maximum with a high ratio of homogeneity and it can be observed that homogeneity of the 360 
process is more influenced by the feed rate than by the L/S ratio.    361 
At high torque velocities (Figures 9c and d) homogeneity decreases with respect to the low 362 
torque velocities.   The maximum homogeneity for this case does not reach 70% and the greater 363 
diameter which homogeneity over 50 % is not bigger than ȝP.   On the contrary to low 364 
torque velocities, homogeneity and diameter displayed a nearly equal dependence for both 365 
parameters: L/S and feed rate.   The production of homogeneous granules is achieved when the 366 
feed rate and the L/S ratio are at middle point conditions of the range of operation.   At the 367 
same time, the diameter increases proportionally to both.   For instance, Figure 9d would give 368 
a range of operational conditions which produce a target granule diameter.   The most adequate 369 
parameters to produce a homogeneous product would be found in the Figure 9c, corresponding 370 
to a proportion to L/S ratio to Feed rate close to 1.3 to 1.  371 
Besides, comparing low torque velocities (Figures 9 a and b) with high torque velocities 372 
(Figures c and d), it can be concluded WKDWIRUĮ-Lactose monohydrate the degree of filling of 373 
the screw is a very important factor.   At low torques velocities, high degrees of filling are 374 
achieved and the system is more dependant of the amount of powder introduced.   At higher 375 
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velocities, the degree of filling is considerably lower and the system requires a balance between 376 
both parameters to obtain a desirable product.    377 
Granules of microcrystalline cellulose were produced in an identical manner and the results are 378 
presented in Figure 10.   Unlike the previous example, the diameter profiles (Figures 10 b and 379 
d) show nearly equal dependence to both parameters L/S ratio and feed rate in both cases of 380 
torque velocity. However, there is a great difference between the diameters of the particles 381 
resulting in granules up to seven times larger than when the system is operated at low torque 382 
velocities. 383 
On the contrary, homogeneity (Figures 10 a and c) shows greater dependence to the L/S ratio 384 
than to feed rate.  Furthermore, at L/S ratios above 1.52, the product reaches homogeneities of 385 
over 50% in both cases.  Comparing the differences between contours profiles at low and high 386 
torque velocities indicates that the degree of filling is one of the main factors to take into 387 
account in the cellulose microcrystalline example as the low torque velocities show more 388 
disturbances than the high torque velocities.    389 
In addition to the study individual effects, a comparison between Figures 9 and 10 permits 390 
appreciation of the strong behavioural differences between both materials.  The growth of both 391 
microcrystalline cellulose and Į-Lactose monohydrate granules depends dramatically on the 392 
L/S ratio, feed rate and torque velocities. Microcrystalline cellulose displays a dramatically 393 
greater dependence to the amount of liquid present in the system than Į-Lactose monohydrate.   394 
This effect agrees with the molecular differences of both materials and the capability of 395 
microcrystalline cellulose to physically hold higher amounts of water WKDQ Į-Lactose 396 
monohydrate (Fielden et al., 1988).  In addition, these results agree with the outcomes reported 397 
by Dhenge et al., where larger granules were also found at the higher L/S ratios (Barrasso et 398 
al., 2013; Dhenge et al., 2010).   Furthermore, it was described that an increase in powder feed 399 
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rates reduced the number of peaks in the PSDs (Dhenge et al., 2011), which corresponds with 400 
the increase of homogeneity reported in the case of low torque velocities for both materials.   401 
Although the most homogeneous product for the studied range were obtained, not all the 402 
experimental results can be entirely compared with those presented in the literature due to the 403 
crucial role of the screw elements configuration. However, this and published studies all 404 
present similar responses to the modifications of the operational parameters as well as similar 405 
range of diameters of granules which indicates the validity of this proposed analysis method.    406 
Furthermore, this analysis identified the degree of filling as a limiting operational parameter 407 
for both materials which will require to be measured quantitatively in further studies of the 408 
equipment.     409 
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4. CONCLUSIONS 410 
A new methodology for measuring homogeneity of particle size distribution was introduced 411 
and validated through its use in two different cases of granulation.   The method is able to 412 
calculate the homogeneity of PSDs with different shapes allowing easy numerical comparison.   413 
The method responded to different modifications such as the addition of peaks, increments on 414 
the variation of the distribution or discrepancies between the main diameter and main particle 415 
size class.   The improvement of this method with respect to the traditional measures such as 416 
span was demonstrated through the comparison of PSD curves with different shape but similar 417 
span.   In addition, the potential of the quantification of homogeneity was demonstrated through 418 
the application to simple liquid granulation with two different excipients.   In both cases, it was 419 
demonstrated that knowing the diameter individually does not give enough information for the 420 
ideal conditions to operate or which operational parameters have more influence on the process.   421 
Therefore, using homogeneity as a quantified quality attribute leads to a better understanding 422 
of powder technology and its possible implementation as characterisation tool in the design 423 
and control of wet granulation systems.   Future work will involve the study of this tool as 424 
process control variable through a sensitivity analysis in an inline process analytical technique.    425 
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)LJXUH 8QLPRGDODDQGSRO\PRGDOESDUWLFOHVL]HDQGFXPXODWLYHGLVWULEXWLRQV 431 
Figure 2. Unimodal (a) and polymodal (b, c) particle size distributions transformed to the 432 
equivalent weight distributions (d). 433 
)LJXUH'HVLJQRIH[SHULPHQWVIRUĮ-Lactose monohydrate (a) and cellulose microcrystalline 434 
(b). 435 
Figure 4. Equivalent particle size distributions (a) transformed to weight distributions (b).  436 
Figure 5. Area under the weight distributions. 437 
Figure 6. Methodology flowchart. 438 
Figure 7. Study of the effect of the deviations produced by a change in the amplitude of the 439 
peak (a, e), increase of the number of peaks (b, c, f) and distance between the peaks (d, g).  440 
Figure 8.  Granules with homogeneity 0% (a), 38.3% (b) and 74.8% (c). 441 
Figure 9.  Homogeneity and diameter contour profiles for Į-Lactose monohydrate: low torque 442 
velocities (a, b) and high torque velocities (c, d).  443 
Figure 10.  Homogeneity and diameter contour profiles for cellulose microcrystalline: low 444 
torque velocities (a, b) and high torque velocities (c, d).  445 
 446 
 447 
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